Lu-177 production begins at Canada’s Bruce NPP

Framatome and Korea Hydro & Nuclear Power (KHNP) have announced the signing of a memorandum of understanding to explore the possibility of producing the medical isotope lutetium-177 at...

An official groundbreaking last week at Framatome’s Mill Ridge Road facility, in Lynchburg, Va., marks the start of a $50 million expansion and an eventual addition of 500 employees,...

Bulgarian officials have approved the transition to Westinghouse fuel at the nation's Kozloduy nuclear power plant, as Bulgaria moves away from its reliance on Russian supplies. The fuel was...

French nuclear developer Framatome is slated to deliver key equipment for Sizewell C Ltd.’s two large reactors planned for the United Kingdom’s Suffolk coast.The agreement, reportedly...

The Canadian government has announced up to C$50 million ($36.8 million) in funding for predevelopment work to study the feasibility of building 4,800 megawatts of new generating capacity at...

According to the Council on Radionuclides and Radiopharmaceuticals, more than 82,000 nuclear imaging procedures using nuclear medicine are performed throughout the world every day. To ...

Radiopharmaceutical biotech company ITM Isotope Technologies Munich announced it has received regulatory approval to begin production of the medical radioisotope lutetium-177 at the...

Framatome and Nuclearelectrica, operator of Romania’s Cernavoda nuclear power plant, announced the signing of a memorandum of understanding to explore the possibility of producing the...

Framatome Inc. and Ultra Safe Nuclear Corp. (USNC) signed an agreement on November 28 at the World Nuclear Exhibition in Paris, France, establishing a joint venture to manufacture nuclear fuel...